首页> 外国专利> COMPOSITION FOR PREVENTING, IMPROVING OR TREATING OF TH2-MEDIATED IMMUNE DISEASE COMPRISING EXTRACTS FROM PANAX NOTOGINSEUG, SAPONARIA OFFICINALIS L. , GLYCINE MAX L., PHASEOLUS RADIATUS L., PHASEOLUS VULGARIS L.

COMPOSITION FOR PREVENTING, IMPROVING OR TREATING OF TH2-MEDIATED IMMUNE DISEASE COMPRISING EXTRACTS FROM PANAX NOTOGINSEUG, SAPONARIA OFFICINALIS L. , GLYCINE MAX L., PHASEOLUS RADIATUS L., PHASEOLUS VULGARIS L.

机译:用于预防,改善或治疗由人参,人参,甘氨酸MAX,L。PHASEOLUS RADIATUS L.,菜豆PHASEOLUS L.得州人参提取物组成的TH2介导的免疫疾病的组合物。

摘要

The present invention relates to a composition containing at least one extract selected from the group consisting of an extract of Panax notoginseug, an extract of Saponaria Officinalis L. leaves, an extract of Glycine max L. leaves, an extract of Phaseolus radiatus L. leaves, and an extract of Phaseolus vulgaris L. leaves as an active ingredient for improving, preventing, or treating Th2-mediated immune disease. The composition of the present invention has downregulatory activities on production of nitric oxide (NO), tumor necrosis factor-alpha (TNF-), and IgE and provides inexpensive production costs and ease of use by using natural substances as raw materials.
机译:本发明涉及一种组合物,其包含至少一种选自三七提取物,皂角叶提取物,最大大豆叶提取物,菜豆叶提取物的提取物。以及菜豆的叶提取物作为改善,预防或治疗Th2介导的免疫疾病的有效成分。本发明的组合物对一氧化氮(NO),肿瘤坏死因子-α(TNF-)和IgE的产生具有下调活性,并且通过使用天然物质作为原料提供廉价的生产成本和易于使用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号